Sleep Apnea and Metabolic Dysfunction

Principles and Practice of Sleep Medicine

Volumn , Issue , 2005, Pages 1034-1042

  Punjabi, Naresh M ^a,b   Beamer, Brock A ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33749241606     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B0-72-160797-7/50093-8     Document Type: Chapter

References (101)

1. Young T, Peppard PE, Gottlieb DJ Epidemiology of obstructive sleep apnea: A population health perspective. Am J Respir Crit Care Med 2002, 165:1217-1239.
2. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993, 328:1230-1235.
3. Redline S, Kump K, Tishler PV, et al. Gender differences in sleep disordered breathing in a community-based sample. Am J Respir Crit Care Med 1994, 149:722-726.
4. Bixler EO, Vgontzas AN, Lin HM, et al. Prevalence of sleep-disordered breathing in women: Effects of gender. Am J Respir Crit Care Med 2001, 163:608-613.
5. Young T, Shahar E, Nieto FJ, et al. Predictors of sleep-disordered breathing in community-dwelling adults: The Sleep Heart Health Study. Arch Intern Med 2002, 162:893-900.
6. Bixler EO, Vgontzas AN, Ten Have T, et al. Effects of age on sleep apnea in men: I. Prevalence and severity. Am J Respir Crit Care Med 1998, 157:144-148.
7. Duran J, Esnaola S, Rubio R, Iztueta A Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Respir Crit Care Med 2001, 163:685-689.
8. Redline S, Tishler PV, Hans MG, et al. Racial differences in sleep-disordered breathing in African-Americans and Caucasians. Am J Respir Crit Care Med 1997, 155:186-192.
9. Olson LG, King MT, Hensley MJ, Saunders NA A community study of snoring and sleep-disordered breathing. Prevalence. Am J Respir Crit Care Med 1995, 152:711-716.
10. Shinohara E, Kihara S, Yamashita S, et al. Visceral fat accumulation as an important risk factor for obstructive sleep apnoea syndrome in obese subjects. J Intern Med 1997, 241:11-18.
11. Ferini-Strambi L, Zucconi M, Castronovo V, et al. Snoring and sleep apnea: A population study in Italian women. Sleep 1999, 22:859-864.
12. Newman AB, Nieto FJ, Guidry U, et al. Relation of sleep-disordered breathing to cardiovascular disease risk factors: The Sleep Heart Health Study. Am J Epidemiol 2001, 154:50-59.
13. Hoffstein V, Mateika S Differences in abdominal and neck circumferences in patients with and without obstructive sleep apnoea. Eur Respir J 1992, 5:377-381.
14. Grunstein R, Wilcox I, Yang TS, et al. Snoring and sleep apnoea in men: Association with central obesity and hypertension. Int J Obes Relat Metab Disord 1993, 17:533-540.
15. Jennum P, Sjol A Snoring, sleep apnoea and cardiovascular risk factors: The MONICA II Study. Int J Epidemiol 1993, 22:439-444.
16. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 1998, 21:518-524.
17. Rewers M, Hamman RF Risk factors for non-insulin dependent diabetes mellitus. National Diabetes Group: Diabetes in America 1995, 179-220. US Government Printing Office, Washington, DC, PDF available at http://diabetes.niddk.nih.gov/dm/pubs/america/. 2nd ed.
18. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2004, 27(Suppl 1):S5-S10.
19. American Diabetes Association Screening for type 2 diabetes. Diabetes Care 2004, 27(Suppl 1):S11-S14.
20. Harris MI Classification, diagnostic criteria, and screening for diabetes. National Diabetes Group: Diabetes in America 1995, 15-36. US Government Printing Office, Washington, DC, PDF available at http://diabetes.niddk.nih.gov/dm/pubs/america/. 2 ed.
21. Engelgau MM, Herman WH, Smith PJ, et al. The epidemiology of diabetes and pregnancy in the U.S., 1988. Diabetes Care 1995, 18:1029-1033.
22. DECODE Study Group Glucose tolerance and mortality: Comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe. Lancet 1999, 354:617-621.
23. Coutinho M, Gerstein HC, Wang Y, Yusuf S The relationship between glucose and incident cardiovascular events. A meta-regression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 1999, 22:233-240.
24. DeFronzo RA, Tobin JD, Andres R Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol 1979, 237:E214-E223.
25. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
26. Caro JF Insulin resistance in obese and nonobese man. J Clin Endocrinol Metab 1991, 73:691-695.
27. Bergman RN, Finegood DT, Ader M Assessment of insulin sensitivity in vivo. Endocr Rev 1985, 6:45-86.
28. Guilleminault C, Briskin JG, Greenfield MS, Silvestri R The impact of autonomic nervous system dysfunction on breathing during sleep. Sleep 1981, 4:263-278.
29. Rees PJ, Prior JG, Cochrane GM, Clark TJ Sleep apnoea in diabetic patients with autonomic neuropathy. J R Soc Med 1981, 74:192-195.
30. Catterall JR, Calverley PM, Ewing DJ, et al. Breathing, sleep, and diabetic autonomic neuropathy. Diabetes 1984, 33:1025-1027.
31. Mondini S, Guilleminault C Abnormal breathing patterns during sleep in diabetes. Ann Neurol 1985, 17:391-395.
32. Neumann C, Martinez D, Schmid H Nocturnal oxygen desaturation in diabetic patients with severe autonomic neuropathy. Diabetes Res Clin Pract 1995, 28:97-102.
33. Ficker JH, Dertinger SH, Siegfried W, et al. Obstructive sleep apnoea and diabetes mellitus: The role of cardiovascular autonomic neuropathy. Eur Respir J 1998, 11:14-19.
34. Resnick HE, Redline S, Shahar E, et al. Diabetes and sleep disturbances: Findings from the Sleep Heart Health Study. Diabetes Care 2003, 26:702-709.
35. Hein MS, Schlenker EH, Patel KP Altered control of ventilation in streptozotocin-induced diabetic rats. Proc Soc Exp Biol Med 1994, 207:213-219.
36. Polotsky VY, Wilson JA, Haines AS, et al. The impact of insulin-dependent diabetes on ventilatory control in the mouse. Am J Respir Crit Care Med 2001, 163:624-632.
37. Bottini P, Dottorini ML, Cristina CM, et al. Sleep-disordered breathing in nonobese diabetic subjects with autonomic neuropathy. Eur Respir J 2003, 22:654-660.
38. Elmasry A, Janson C, Lindberg E, et al. The role of habitual snoring and obesity in the development of diabetes: A 10-year follow-up study in a male population. J Intern Med 2000, 248:13-20.
39. Al Delaimy WK, Manson JE, Willett WC, et al. Snoring as a risk factor for type II diabetes mellitus: A prospective study. Am J Epidemiol 2002, 155:387-393.
40. Enright PL, Newman AB, Wahl PW, et al. Prevalence and correlates of snoring and observed apneas in 5,201 older adults. Sleep 1996, 19:531-538.
41. Grunstein RR, Stenlof K, Hedner J, Sjostrom L Impact of obstructive sleep apnea and sleepiness on metabolic and cardiovascular risk factors in the Swedish Obese Subjects (SOS) Study. Int J Obes Relat Metab Disord 1995, 19:410-418.
42. Jennum P, Schultz-Larsen K, Christensen N Snoring, sympathetic activity and cardiovascular risk factors in a 70 year old population. Eur J Epidemiol 1993, 9:477-482.
43. Levinson PD, McGarvey ST, Carlisle CC, et al. Adiposity and cardiovascular risk factors in men with obstructive sleep apnea. Chest 1993, 103:1336-1342.
44. Tiihonen M, Partinen M, Narvanen S The severity of obstructive sleep apnoea is associated with insulin resistance. J Sleep Res 1993, 2:56-61.
45. Davies RJ, Turner R, Crosby J, Stradling JR Plasma insulin and lipid levels in untreated obstructive sleep apnoea and snoring: Their comparison with matched controls and response to treatment. J Sleep Res 1994, 3:180-185.
46. Strohl KP, Novak RD, Singer W, et al. Insulin levels, blood pressure and sleep apnea. Sleep 1994, 17:614-618.
47. Stoohs RA, Facchini F, Guilleminault C Insulin resistance and sleep-disordered breathing in healthy humans. Am J Respir Crit Care Med 1996, 154:170-174.
48. Ip MS, Lam KS, Ho C, et al. Serum leptin and vascular risk factors in obstructive sleep apnea. Chest 2000, 118:580-586.
49. Vgontzas AN, Papanicolaou DA, Bixler EO, et al. Sleep apnea and daytime sleepiness and fatigue: Relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 2000, 85:1151-1158.
50. Elmasry A, Lindberg E, Berne C, et al. Sleep-disordered breathing and glucose metabolism in hypertensive men: A population-based study. J Intern Med 2001, 249:153-161.
51. De La Eva RC, Baur LA, Donaghue KC, Waters KA Metabolic correlates with obstructive sleep apnea in obese subjects. J Pediatr 2002, 140:654-659.
52. Ip MS, Lam B, Ng MM, et al. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002, 165:670-676.
53. Manzella D, Parillo M, Razzino T, et al. Soluble leptin receptor and insulin resistance as determinant of sleep apnea. Int J Obes Relat Metab Disord 2002, 26:370-375.
54. Punjabi NM, Sorkin JD, Katzel LI, et al. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 2002, 165:677-682.
55. Coughlin SR, Mawdsley L, Mugarza JA, et al. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 2004, 25:735-741.
56. Punjabi NM, Shahar E, Redline S, et al. Sleep-disordered breathing, glucose intolerance, and insulin resistance: The Sleep Heart Health Study. Am J Epidemiol 2004, 160(6):521-530.
57. Saini J, Krieger J, Brandenberger G, et al. Continuous positive airway pressure treatment. Effects on growth hormone, insulin and glucose profiles in obstructive sleep apnea patients. Horm Metab Res 1993, 25:375-381.
58. Stoohs RA, Facchini FS, Philip P, et al. Selected cardiovascular risk factors in patients with obstructive sleep apnea: Effect of nasal continuous positive airway pressure (n-CPAP). Sleep 1993, 16:S141-S142.
59. Brooks B, Cistulli PA, Borkman M, et al. Obstructive sleep apnea in obese noninsulin-dependent diabetic patients: Effect of continuous positive airway pressure treatment on insulin responsiveness. J Clin Endocrinol Metab 1994, 79:1681-1685.
60. Cooper BG, White JE, Ashworth LA, et al. Hormonal and metabolic profiles in subjects with obstructive sleep apnea syndrome and the acute effects of nasal continuous positive airway pressure (CPAP) treatment. Sleep 1995, 18:172-179.
61. Saarelainen S, Lahtela J, Kallonen E Effect of nasal CPAP treatment on insulin sensitivity and plasma leptin. J Sleep Res 1997, 6:146-147.
62. Chin K, Shimizu K, Nakamura T, et al. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 1999, 100:706-712.
63. Smurra M, Philip P, Taillard J, et al. CPAP treatment does not affect glucose-insulin metabolism in sleep apneic patients. Sleep Med 2001, 2:207-213.
64. Harsch IA, Schahin SP, Radespiel-Troqer M, et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2003, 169:156-162.
65. Larsen JJ, Hansen JM, Olsen NV, et al. The effect of altitude hypoxia on glucose homeostasis in men. J Physiol (Lond) 1997, 504(pt 1):241-249.
66. Braun B, Rock PB, Zamudio S, et al. Women at altitude: Short-term exposure to hypoxia and/or alpha(1)-adrenergic blockade reduces insulin sensitivity. J Appl Physiol 2001, 91:623-631.
67. Cheng N, Cai W, Jiang M, Wu S Effect of hypoxia on blood glucose, hormones, and insulin receptor functions in newborn calves. Pediatr Res 1997, 41:852-856.
68. RaffH, Bruder ED, Jankowski BM The effect of hypoxia on plasma leptin and insulin in newborn and juvenile rats. Endocrine 1999, 11:37-39.
69. RaffH, Bruder ED, Jankowski BM, Colman RJ Effect of neonatal hypoxia on leptin, insulin, growth hormone and body composition in the rat. Horm Metab Res 2001, 33:151-155.
70. Polotsky VY, Li J, Punjabi NM, et al. Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol 2003, 552:253-264.
71. Bergman RN, Phillips LS, Cobelli C Physiologic evaluation of factors controlling glucose tolerance in man: Measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 1981, 68:1456-1467.
72. Spiegel K, Leproult R, Van Cauter E Impact of sleep debt on metabolic and endocrine function. Lancet 1999, 354:1435-1439.
73. Narkiewicz K, Somers VK Sympathetic nerve activity in obstructive sleep apnoea. Acta Physiol Scand 2003, 177:385-390.
74. Nonogaki K New insights into sympathetic regulation of glucose and fat metabolism. Diabetologia 2000, 43:533-549.
75. Bartness TJ, Bamshad M Innervation of mammalian white adipose tissue: Implications for the regulation of total body fat. Am J Physiol 1998, 275:R1399-R1411.
76. Boden G Free fatty acids, insulin resistance, and type 2 diabetes mellitus. Proc Assoc Am Physicians 1999, 111:241-248.
77. Leproult R, Copinschi G, Buxton O, Van Cauter E Sleep loss results in an elevation of cortisol levels the next evening. Sleep 1997, 20:865-870.
78. Bratel T, Wennlund A, Carlstrom K Pituitary reactivity, androgens and catecholamines in obstructive sleep apnoea. Effects of continuous positive airway pressure treatment (CPAP). Respir Med 1999, 93:1-7.
79. Bloom SR, Edwards AV, Hardy RN, Silver M Adrenal and pancreatic endocrine responses to hypoxia in the conscious calf. J Physiol 1976, 261:271-283.
80. Bloom SR, Edwards AV, Hardy RN Adrenal and pancreatic endocrine responses to hypoxia and hypercapnia in the calf. J Physiol 1977, 269:131-154.
81. Andrews RC, Walker BR Glucocorticoids and insulin resistance: Old hormones, new targets. Clin Sci (Lond) 1999, 96:513-523.
82. Leal-Cerro A, Soto A, Martinez MA, et al. Influence of cortisol status on leptin secretion. Pituitary 2001, 4:111-116.
83. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 2001, 280:E745-E751.
84. Fernandez-Real JM, Vayreda M, Richart C, et al. Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab 2001, 86:1154-1159.
85. Pradhan AD, Manson JE, Rifai N, et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001, 286:327-334.
86. Klausen T, Olsen NV, Poulsen TD, et al. Hypoxemia increases serum interleukin-6 in humans. Eur J Appl Physiol Occup Physiol 1997, 76:480-482.
87. Hartmann G, Tschop M, Fischer R, et al. High altitude increases circulating interleukin-6, interleukin-1 receptor antagonist and C-reactive protein. Cytokine 2000, 12:246-252.
88. Liu H, Liu J, Xiong S, et al. The change of interleukin-6 and tumor necrosis factor in patients with obstructive sleep apnea syndrome. J Tongji Med Univ 2000, 20:200-202.
89. Yokoe T, Minoguchi K, Matsuo H, et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003, 107:1129-1134.
90. Ventre J, Doebber T, Wu M, et al. Targeted disruption of the tumor necrosis factor-alpha gene: metabolic consequences in obese and nonobese mice. Diabetes 1997, 46:1526-1531.
91. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997, 389:610-614.
92. Peraldi P, Xu M, Spiegelman BM Thiazolidinediones block tumor necrosis factor-alpha-induced inhibition of insulin signaling. J Clin Invest 1997, 100:1863-1869.
93. Vgontzas AN, Zoumakis E, Lin HM, et al. Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist. J Clin Endocrinol Metab 2004, 89(9):4409-4413.
94. Ceddia RB, Koistinen HA, Zierath JR, Sweeney G Analysis of paradoxical observations on the association between leptin and insulin resistance. FASEB J 2002, 16:1163-1176.
95. Grosfeld A, Zilberfarb V, Turban S, et al. Hypoxia increases leptin expression in human PAZ6 adipose cells. Diabetologia 2002, 45:527-530.
96. Chin K, Shimizu K, Nakamura T, et al. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 1999, 100:706-712.
97. Phillips BG, Kato M, Narkiewicz K, et al. Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol 2000, 279:H234-H237.
98. Shimizu K, Chin K, Nakamura T, et al. Plasma leptin levels and cardiac sympathetic function in patients with obstructive sleep apnoea-hypopnoea syndrome. Thorax 2002, 57:429-434.
99. Chin K, Nakamura T, Takahashi K, et al. Effects of obstructive sleep apnea syndrome on serum aminotransferase levels in obese patients. Am J Med 2003, 114:370-376.
100. Ozturk L, Unal M, Tamer L, Celikoglu F The association of the severity of obstructive sleep apnea with plasma leptin levels. Arch Otolaryngol Head Neck Surg 2003, 129:538-540.
101. Sanner BM, Kollhosser P, Buechner N, et al. Influence of treatment on leptin levels in patients with obstructive sleep apnoea. Eur Respir J 2004, 23:601-604.